5F9E | Transferase Transferase Inhibitor | date | Dec 09, 2015 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure Of Protein Kinase C Theta With Compound 10: 2,2-Di (2-Oxidanylidene-3~{H}-Imidazo[4,5-B]Pyridin-1-Yl)-1-(Pheny 3~{H}-Quinazolin-4-One | ||||||||||||||
authors | M.Klein | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Protein Kinase C Theta Type Chain: A, B Synonym: Npkc-Theta Ec: 2.7.11.13 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Prkcq, Prkct Expression_system: Unidentified Baculovirus Expression_system_taxid: 10469 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.00 Å | ||||||||||||
ligand | 5VS, SEP | enzyme | Transferase E.C.2.7.11.13 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCtheta inhibitors., Katoh T, Takai T, Yukawa T, Tsukamoto T, Watanabe E, Mototani H, Arita T, Hayashi H, Nakagawa H, Klein MG, Zou H, Sang BC, Snell G, Nakada Y, Bioorg Med Chem. 2016 Jun 1;24(11):2466-75. doi: 10.1016/j.bmc.2016.04.008. Epub , 2016 Apr 4. PMID:27117263 |
Data retrieval |
View 5F9E in 3D |
Visual 3D analysis of 5F9E |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5F9E |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |